A synthetic luciferin improves bioluminescence imaging in live mice

Nature Methods volume 11, pages393–395(2014)Cite this article

Subjects

This article has been updated

Abstract

Firefly luciferase is the most widely used optical reporter for noninvasive bioluminescence imaging (BLI) in rodents. BLI relies on the ability of the injected luciferase substrate D-luciferin to access luciferase-expressing cells and tissues within the animal. Here we show that injection of mice with a synthetic luciferin, CycLuc1, improves BLI with existing luciferase reporters and enables imaging in the brain that could not be achieved with D-luciferin.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

Rent or Buy

All prices are NET prices.

Figure 1: BLI of tumor xenografts with D-luciferin and CycLuc1.
Figure 2: Comparison of D-luciferin and CycLuc1 in luciferase-expressing transgenic mice.
Figure 3: Comparison of D-luciferin and CycLuc1 in the brain.

Change history

  • 13 February 2014

    In the version of this article initially published online, the author name Miranda A. Paley was incorrectly spelled as Miranwda A. Paley. The error has been corrected for the print, PDF and HTML versions of this article.

References

  1. 1

    Contag, C.H. & Bachmann, M.H. Annu. Rev. Biomed. Eng. 4, 235–260 (2002).

    CAS  Article  Google Scholar 

  2. 2

    Dothager, R.S. et al. Curr. Opin. Biotechnol. 20, 45–53 (2009).

    CAS  Article  Google Scholar 

  3. 3

    Prescher, J.A. & Contag, C.H. Curr. Opin. Chem. Biol. 14, 80–89 (2010).

    CAS  Article  Google Scholar 

  4. 4

    Rabinovich, B.A. et al. Proc. Natl. Acad. Sci. USA 105, 14342–14346 (2008).

    CAS  Article  Google Scholar 

  5. 5

    Kim, J.-B. et al. PLoS ONE 5, e9364 (2010).

    Article  Google Scholar 

  6. 6

    Mezzanotte, L. et al. Mol. Imaging Biol. 12, 406–414 (2010).

    Article  Google Scholar 

  7. 7

    Harwood, K.R., Mofford, D.M., Reddy, G.R. & Miller, S.C. Chem. Biol. 18, 1649–1657 (2011).

    CAS  Article  Google Scholar 

  8. 8

    Shinde, R., Perkins, J. & Contag, C.H. Biochemistry 45, 11103–11112 (2006).

    CAS  Article  Google Scholar 

  9. 9

    Berger, F., Paulmurugan, R., Bhaumik, S. & Gambhir, S.S. Eur. J. Nucl. Med. Mol. Imaging 35, 2275–2285 (2008).

    Article  Google Scholar 

  10. 10

    Kojima, R. et al. Angew. Chem. Int. Edn. Engl. 52, 1175–1179 (2013).

    CAS  Article  Google Scholar 

  11. 11

    Conley, N.R., Dragulescu-Andrasi, A., Rao, J. & Moerner, W.E. Angew. Chem. Int. Ed. 51, 3350–3353 (2012).

    CAS  Article  Google Scholar 

  12. 12

    Zhao, H. et al. J. Biomed. Opt. 10, 41210 (2005).

    Article  Google Scholar 

  13. 13

    McCutcheon, D.C., Paley, M.A., Steinhardt, R.C. & Prescher, J.A. J. Am. Chem. Soc. 134, 7604–7607 (2012).

    CAS  Article  Google Scholar 

  14. 14

    Woodroofe, C.C. et al. Biochemistry 51, 9807–9813 (2012).

    CAS  Article  Google Scholar 

  15. 15

    Reddy, G.R., Thompson, W.C. & Miller, S.C. J. Am. Chem. Soc. 132, 13586–13587 (2010).

    CAS  Article  Google Scholar 

  16. 16

    Woodroofe, C.C. et al. Biochemistry 47, 10383–10393 (2008).

    CAS  Article  Google Scholar 

  17. 17

    Cao, Y.-A. et al. Proc. Natl. Acad. Sci. USA 101, 221–226 (2004).

    CAS  Article  Google Scholar 

  18. 18

    Zhang, H. et al. Mol. Ther. 19, 1440–1448 (2011).

    CAS  Article  Google Scholar 

  19. 19

    Safran, M. et al. Mol. Imaging 2, 297–302 (2003).

    CAS  Article  Google Scholar 

  20. 20

    Madisen, L. et al. Nat. Neurosci. 13, 133–140 (2010).

    CAS  Article  Google Scholar 

  21. 21

    Bäckman, C.M. et al. Genesis 44, 383–390 (2006).

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the US National Institutes of Health (R01EB013270 to S.C.M. and NS38194 to N.A.), the CHDI (to N.A.), the American Cancer Society (IRG-98-279-07 to J.A.P.) and the University of California, Irvine, School of Physical Sciences (to J.A.P.).

Author information

Author notes

  1. Melanie S Evans and Joanna P Chaurette: These authors contributed equally to this work.

Affiliations

  1. Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, California, USA

    Melanie S Evans & Jennifer A Prescher

  2. Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA

    Joanna P Chaurette & Neil Aronin

  3. RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, Massachusetts, USA

    Joanna P Chaurette & Neil Aronin

  4. Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA

    Spencer T Adams Jr, Gadarla R Reddy & Stephen C Miller

  5. Department of Chemistry, University of California, Irvine, Irvine, California, USA

    Miranda A Paley & Jennifer A Prescher

Authors
  1. Melanie S Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanna P Chaurette
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Spencer T Adams Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gadarla R Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Miranda A Paley
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Neil Aronin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jennifer A Prescher
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Stephen C Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M.S.E. and J.A.P. imaged tumors and L2G85-FVB mice, G.R.R. synthesized CycLuc1, M.A.P. imaged cultured cells, J.P.C. bred Dat mice, S.T.A. and J.P.C. imaged AAV9 and Dat mice, N.A. contributed to the development of AAV9 and Dat mouse models and manuscript editing, S.C.M. designed CycLuc1, and S.C.M. and J.A.P. led the study and wrote the manuscript.

Corresponding authors

Correspondence to Jennifer A Prescher or Stephen C Miller.

Ethics declarations

Competing interests

The University of Massachusetts Medical School, at which some of the authors are employed, holds patents on luciferin substrates (US7910087 and US8216550), for which the assignee is the University of Massachusetts and the inventor is Stephen C. Miller.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–10 (PDF 5299 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Evans, M., Chaurette, J., Adams, S. et al. A synthetic luciferin improves bioluminescence imaging in live mice. Nat Methods 11, 393–395 (2014). https://doi.org/10.1038/nmeth.2839

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing